These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 788857)

  • 21. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)].
    Loisseau P; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320
    [No Abstract]   [Full Text] [Related]  

  • 23. Hematological effects of valproate in psychiatric patients: what are the risk factors?
    Vasudev K; Keown P; Gibb I; McAllister-Williams RH
    J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperglycinuria induced by n-dipropylacetate. Possible model of propionic acidemia].
    Kamoun P; Parvy P; Debray-Ritzen P
    Nouv Presse Med; 1977 Jun; 6(24):2162. PubMed ID: 333384
    [No Abstract]   [Full Text] [Related]  

  • 25. Transient thrombocytopenia in a child on sodium valproate.
    Cole AP
    Dev Med Child Neurol; 1978 Aug; 20(4):487-90. PubMed ID: 357235
    [No Abstract]   [Full Text] [Related]  

  • 26. Sodium valproate and thrombocytopenia.
    Hoffman LM
    Can Med Assoc J; 1982 Feb; 126(4):358-9. PubMed ID: 6802479
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombocytopenia associated with sodium valproate treatment.
    Neophytides AN; Nutt JG; Lodish JR
    Ann Neurol; 1979 Apr; 5(4):389-90. PubMed ID: 375808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epilepsy and IgA deficiency--the effect of sodium valproate.
    Joubert PH; Aucamp AK; Potgieter GM; Verster F
    S Afr Med J; 1977 Oct; 52(16):642-4. PubMed ID: 337537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium valproate and bone marrow suppression.
    Smith FR; Boots M
    Ann Neurol; 1980 Aug; 8(2):197-9. PubMed ID: 6775583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W; Beydoun A
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombocytopenia secondary to high valproate levels in children with epilepsy.
    Delgado MR; Riela AR; Mills J; Browne R; Roach ES
    J Child Neurol; 1994 Jul; 9(3):311-4. PubMed ID: 7930412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid and thrombocytopenia. Case report.
    Patel CC; Church S; Reilly KM
    J Ky Med Assoc; 1982 Apr; 80(4):213-5. PubMed ID: 6808068
    [No Abstract]   [Full Text] [Related]  

  • 34. [Problems posed by the therapeutic combination of phenobarbital and sodium dipropylacetate. Apropos of a case].
    Millet Y; Sainty JM; Galland MC; Sidoine R; Jouglard J
    Eur J Toxicol Environ Hyg; 1976; 9(6):381-3. PubMed ID: 799967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium valproate: a new anticonvulsant.
    Med Lett Drugs Ther; 1977 Nov; 19(23):93-4. PubMed ID: 337093
    [No Abstract]   [Full Text] [Related]  

  • 36. Side effect profile of enteric-coated divalproex sodium versus valproic acid.
    Levine J; Chengappa KN; Parepally H
    J Clin Psychiatry; 2000 Sep; 61(9):680-1. PubMed ID: 11030493
    [No Abstract]   [Full Text] [Related]  

  • 37. Sodium valproate and platelet counts.
    Eastham RD; Jancar J
    Br Med J; 1980 Jan; 280(6208):186. PubMed ID: 6766772
    [No Abstract]   [Full Text] [Related]  

  • 38. Haematological disturbances during long-term valproate therapy.
    Brichard B; Vermylen C; Scheiff JM; Ninane J; Cornu G
    Eur J Pediatr; 1994 May; 153(5):378-80. PubMed ID: 8033931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anticonvulsant effect of sodium valproate and clonazepam in the management of intractable epilepsy.
    Lance JW; Anthony M
    Trans Am Neurol Assoc; 1976; 101():200-4. PubMed ID: 800689
    [No Abstract]   [Full Text] [Related]  

  • 40. Early experience with sodium valproate.
    Ronthal M; Terespolsky PS
    S Afr Med J; 1976 Nov; 50(50):1997-8. PubMed ID: 827029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.